SENSEX NIFTY
Ranbaxy Laboratories

News from other websites on Ranbaxy Laboratories

Sun Pharma third-quarter profit falls

Feb 14, 2015 at 21:30 | Source: FirstPost

MUMBAI (Reuters) - Sun Pharmaceutical Industries Ltd, India's largest drugmaker, said on Saturday third-quarter net profit fell unexpectedly due to a decline in sales in the United States and costs from resolving regulatory issues at a manufacturing ...

US Federal Trade Commission approves Sun Pharma's Ranbaxy acquisition

Feb 02, 2015 at 12:42 | Source: FirstPost

New Delhi: The US Federal Trade Commission (FTC) has completed its review of the proposed USD 4 billion acquisition of Ranbaxy Laboratories by Sun Pharma and granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improv...

Ipca hit by FDA ban over Ratlam plant production violations

Jan 25, 2015 at 00:15 | Source: FirstPost

MUMBAI (Reuters) - U.S. regulator the Food and Drug Administration has banned imports from a Madhya Pradesh manufacturing plant of generic drugmaker Ipca Laboratories Ltd(IPCA.NS), citing violations of standard production practices.India is second on...

Ipca Labs hit by FDA ban on MP plant for standard violations

Jan 23, 2015 at 11:54 | Source: FirstPost

The US Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Ipca Laboratories Ltd's plant at Ratlam in Madhya Pradesh due to violations of standard production practices.Ipca had voluntarily halted shipments to the Unite...

Double blow to Ranbaxy

Nov 07, 2014 at 12:42 | Source: Calcutta Telegraph News

Mumbai, Nov. 6: The US health regulator has revoked tentative approvals to Ranbaxy Laboratories to make the generic versions of AstraZeneca’s heartburn drug Nexium and Roche Holding’s anti-viral Valcyte. The tentative approvals to the tw...

US boost for Ranbaxy net

Oct 29, 2014 at 03:42 | Source: Calcutta Telegraph News

Mumbai, Oct. 28: Ranbaxy Laboratories today reported its first net profit in six quarters, gaining from the exclusive US launch of a cheaper copy of Novartis�s blood pressure pill Diovan. The drug firm, which is being bought by larger rival Sun Ph...

Cadila recalls drug in US

Oct 18, 2014 at 20:22 | Source: Calcutta Telegraph News

Mumbai, Oct. 17: Cadila Healthcare has voluntarily recalled 5,400 bottles of anti-hypertension drug Atenolol tablets in the US for failing to meet specifications. A notification by the US Food and Drug Administration (USFDA) said the recall was volu...

Ranbaxy buys Texas peace

Oct 17, 2014 at 12:32 | Source: Calcutta Telegraph News

Mumbai, Oct. 16: Ranbaxy Laboratories today said it would pay $39.75 million (Rs 244 crore) to the state of Texas in the US to settle the litigation with regard to its participation in a social health scheme meant for the poor. “The company ha...

Strides, Shasun pop merger pill

Sep 30, 2014 at 12:57 | Source: Calcutta Telegraph News

Mumbai, Sept: 29: Chennai-based Shasun Pharmaceuticals Ltd will be merged with generic drug maker Strides Arcolab to create a Rs 2,500-crore entity spanning across multiple segments. The merged entity will figure among the top 15 listed Indian pharm...

Corporate India s legal costs increase 17.5% in 2013-14

Sep 27, 2014 at 13:17 | Source: Economic Times

MUMBAI: An overhead cost is steadily expanding for Indian companies as they aggressively push in overseas markets and regulations become tougher at home and abroad. More than 1,800 listed companies that the ET Intelligence Group has analysed have col...

Drug firms get part price relief

Sep 24, 2014 at 04:47 | Source: Calcutta Telegraph News

New Delhi, Sept. 23: The government has withdrawn the national drug pricing authority’s power to set prices of non-essential medicines, but price caps on the over 100 non-essential drugs that drew the industry’s ire in July will remain. ...

Diabetes to infections medicines: India caps the prices of 36 drugs

Sep 19, 2014 at 16:04 | Source: FirstPost

Mumbai: India has capped the prices of 36 drugs, including those used to treat infections and diabetes, in its latest move to make essential medicines more affordable, a senior official of the country's drug pricing authority said on Friday.The medic...

Ranbaxy under US lens

Sep 18, 2014 at 04:37 | Source: Calcutta Telegraph News

Mumbai, Sept. 17: Ranbaxy Laboratories today said the US justice department had asked it to disclose the way it priced some drugs it sold in America. The Indian company, in fact, had made a provision of Rs 237.75 crore in the first quarter but had n...

Ranbaxy says U.S. authorities seek information on pricing data

Sep 18, 2014 at 00:45 | Source: FirstPost

MUMBAI (Reuters) - Generic drugmaker Ranbaxy Laboratories Ltd (RANB.NS) said on Wednesday that federal authorities in the United States had sought details on how it reports pricing data for some products eligible for reimbursement under the Medicaid ...

Ranbaxy relief

Sep 14, 2014 at 12:02 | Source: Calcutta Telegraph News

Sept. 13 (Reuters): Pfizer Inc and Ranbaxy Laboratories on Friday won dismissal of a US anti-trust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor. US District Judge Peter Sheridan ...

Relief for Ranbaxy as US court dismisses Lipitor antitrust case against co, Pfizer

Sep 13, 2014 at 09:34 | Source: FirstPost

Pfizer Inc and India's Ranbaxy Laboratories Ltd on Friday won dismissal of a US antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor.US District Judge Peter Sheridan in Trenton,...

Nifty retreats from record high on profit taking

Aug 21, 2014 at 00:51 | Source: FirstPost

MUMBAI (Reuters) - The Nifty edged lower on Wednesday, unable to sustain a rally after hitting a third consecutive record high earlier in session as investors took profits in blue-chips such as Oil and Natural Gas Corp(ONGC.NS).The falls ended a six-...

Sun bid to address monopoly concern

Aug 14, 2014 at 04:07 | Source: Calcutta Telegraph News

Mumbai, Aug. 13: Sun Pharma today said it was in discussion with the Competition Commission of India (CCI) to allay apprehensions about the impact of its acquisition of Ranbaxy Laboratories on the domestic pharmaceutical sector. The fair trade watch...

Ranbaxy suffers loss

Jul 31, 2014 at 01:52 | Source: Calcutta Telegraph News

Mumbai, July 29: Ranbaxy Laboratories has suffered a net loss of Rs 185.92 crore for the quarter ended June 30 as it was bogged down by a “settlement provision’’ of nearly Rs 237.75 crore. The company, which is dealing with an impo...

Ipca halts drug exports to US

Jul 25, 2014 at 08:12 | Source: Calcutta Telegraph News

Mumbai, July 24: Ipca Laboratories today said it was voluntarily suspending shipments of drug ingredients from one of its plants in the country, following concerns expressed by the US Food and Drug Administration (FDA). The mid-sized company said th...

video of the day

Budget 2015-16: Revive capex through savings on cheap crude says Kotak Sec

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.